<DOC>
	<DOCNO>NCT00827632</DOCNO>
	<brief_summary>There large gap low expected failure rate 1.5 % typical use failure rate 7 % per year . This gap may due incorrect use decrease oral contraceptive ( OC ) effectiveness population subgroup . Recent report suggest great OC failure among heavy woman , particularly use low dos . The prevalence obesity US population recently increase 23 % woman age 20-29 , peak year OC use . OC physiology effectiveness evaluate obese woman . We propose double blind randomized clinical trial include normal weight obese woman normal ovulatory function baselineÍ¾ randomize woman 2 widely use OCs evaluate ovarian follicle development circulate progesterone ass ovarian suppression OC use .</brief_summary>
	<brief_title>Obesity , Oral Contraception , Ovarian Suppression</brief_title>
	<detailed_description />
	<mesh_term>Vision Disorders</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Aged 1835 Body Mass Index ( BMI ) 1924.9 3039.9 kg/m^2 Willing take birth control pills 34 month Recent spontaneous pregnancy cyclic menses Contraindications hormonal contraceptive Oophorectomy/Polycystic ovary syndrome ( PCOS ) Taken oral contraceptive regulate menses recently Weight reduction surgery Used DepoProvera within last 12 month Pregnant currently breastfeed Desiring pregnancy within next 4 month Unable make study visit commitment Previous participation study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Ovarian Suppression</keyword>
	<keyword>Oral Contraceptives</keyword>
	<keyword>Obese Normal BMI</keyword>
</DOC>